Report post
NVAX stock poised for volatile Monday with investors eagerly anticipating earnings report and price predictions. Deal with Sanofi to co-commercialize Covid vaccine adds optimism, but workforce reduction announcement clouds outlook. Expectations are mixed, with stock potentially soaring or facing headwinds depending on earnings performance.

The World's Leading Crypto Trading Platform

Get my welcome gifts